Vidalista D Tadalafil/Dapoxetine

Vidalista D is listed as a tablet with tadalafil 10 mg and dapoxetine 30 mg. The two amounts belong to different medicines. Read the ingredient and strength lines on the actual pack because a similar product name can refer to another combination. When discussing this tablet with a clinician, bring the full label and explain which symptoms led you to look it up.

Read both amounts before comparing any two packs

The first amount in the 10/30 listing is tadalafil. The second is dapoxetine. Adding the numbers together does not tell you the tadalafil strength. Super Vidalista and Extra Super Vidalista have separate listed amounts for the same two ingredients. Use the product name and both amounts to keep the presentations separate.

The dispensing label is useful if you received a strip without a carton or the print is hard to read. Ask the pharmacy to confirm what was supplied before using it. Keep a copy of the label with the medication. If you later discuss a side effect, a pharmacist needs to know which exact combination you used. If the two packages appear similar, photograph the ingredient lines before storing them. Readable records help if you later need to check which product was supplied.

Describe the symptoms in the order they happen

A patient may have trouble getting or keeping an erection, may ejaculate earlier than intended, or may experience both. The sequence matters because the two symptoms can influence each other. Tell the clinician which concern occurs first, how often it happens, and whether it changed after a new medicine or health issue. That gives the clinician more context than the phrase dual action.

Tadalafil helps support the erection response during sexual stimulation. Dapoxetine is a short-acting selective serotonin reuptake inhibitor used for premature ejaculation in some countries. It has no FDA approval for that use in the United States. A clinician can assess each symptom and decide what treatment is suitable, including whether a combination is appropriate to discuss.

Three details to bring to a medicine review

Bring the exact package name and both strengths, your medication list, and any history of fainting or dizziness on standing. Include medicines used only as needed, such as a chest-pain spray. Also mention antidepressants, tramadol and herbal products such as St. John’s wort. The dapoxetine component can interact with medicines that affect serotonin.

The prescribing information for standalone dapoxetine advises against combining it with a PDE5 inhibitor because standing blood pressure and fainting risk can be affected. Tadalafil is a PDE5 inhibitor. Show both ingredients to a clinician so they can assess that issue, and mention any heart rhythm problem or previous fainting. Alcohol can further increase dizziness or fainting risk with dapoxetine.

Why the tadalafil interaction check still matters

Tadalafil must be avoided with nitrates, recreational nitrites and riociguat. Other medicines that lower blood pressure can matter too. Tell the clinician if you already take daily tadalafil, a medicine for pulmonary hypertension, or a separate ED treatment. Reading a lower tadalafil number on this box does not remove the need to review both ingredients and all current prescriptions.

Headache, flushing, indigestion and muscle discomfort can occur with tadalafil. Dapoxetine can cause nausea or dizziness. If a new symptom starts, note when it began and what you took. Seek immediate help for fainting, chest pain, sudden loss of vision or hearing, or an erection lasting four hours. Take the package or a clear label photo if you need medical care.

What to clarify before a follow-up

Ask which symptom the clinician would address first and which treatment options are appropriate for that symptom. A fixed tablet keeps both amounts together, so it cannot independently adjust one ingredient. Bring the package and your symptom notes if the plan changes. That gives the clinician a record of both the product and the reason you considered it.

Advantages

• The 10/30 listing records separate amounts for the two active ingredients.
• The full label helps distinguish Vidalista D from the other combination names.
• The fixed form gives the pharmacist a clear pair of ingredients to review.
• Knowing both amounts can make a medication discussion more precise.

Disadvantages

• The two ingredients are fixed in one tablet and cannot be adjusted independently.
• Dapoxetine adds restrictions involving fainting, alcohol and medicines that affect serotonin.
• Tadalafil’s nitrate and blood pressure interaction risks remain relevant.

Frequently Asked Questions

Which ingredient is listed at 30 mg in Vidalista D?

The catalog lists dapoxetine at 30 mg and tadalafil at 10 mg. Verify both amounts on the supplied pack.

Why should I explain which symptom came first when discussing this product?

The order can help a clinician separate erection difficulty from ejaculation timing and decide which concern to evaluate first.

What should I disclose about occasional chest-pain medicine before discussing Vidalista D?

Give the exact name, strength and when you last used it. Nitrates can interact dangerously with the tadalafil component.

How does a previous fainting episode affect a 10/30 combination review?

Tell the clinician what happened and whether it occurred after standing or taking a medicine. Dapoxetine product information includes restrictions related to fainting.

What should I do if the strip and listing show different amounts for Vidalista D?

Keep the pack and ask the dispensing pharmacist to verify both active ingredient strengths before using the tablet.

Dapoxetine product information

Clinical guidance on premature ejaculation